Carl Kraus

1.1k total citations
25 papers, 811 citations indexed

About

Carl Kraus is a scholar working on Molecular Biology, Infectious Diseases and Microbiology. According to data from OpenAlex, Carl Kraus has authored 25 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Microbiology. Recurrent topics in Carl Kraus's work include Antimicrobial Peptides and Activities (5 papers), Viral gastroenteritis research and epidemiology (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Carl Kraus is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Viral gastroenteritis research and epidemiology (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Carl Kraus collaborates with scholars based in United States, Germany and Hungary. Carl Kraus's co-authors include Clifton E. Barry, Harvey Rubin, Gilla Kaplan, John L. Dahl, Helena I. Boshoff, Valerie Mizrahi, David Avarbock, David DeShazer, John G. Bartlett and James D. Dick and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Clinical Infectious Diseases.

In The Last Decade

Carl Kraus

24 papers receiving 780 citations

Peers

Carl Kraus

EPIDE

GENET

Jan Egil Afset Norway

Amanda Harrington United States

Ana A. Weil United States

Stuart McCorrister Canada

Felicia Ruffin United States

Christopher Duplessis United States

Sam Willcocks United Kingdom

Anne Stranden Switzerland

Chunhui Li China

Gesham Magombedze United States

Jan Egil Afset Norway

Carl Kraus

265 ×0.7

EPIDE

580 ×1.9

179 ×0.7

93 ×0.9

98 ×1.1

GENET

Citations per year, relative to Carl Kraus Carl Kraus (= 1×) peers Jan Egil Afset

Countries citing papers authored by Carl Kraus

Since Specialization

Citations

This map shows the geographic impact of Carl Kraus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Kraus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Kraus more than expected).

Fields of papers citing papers by Carl Kraus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Kraus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Kraus. The network helps show where Carl Kraus may publish in the future.

Co-authorship network of co-authors of Carl Kraus

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Kraus. A scholar is included among the top collaborators of Carl Kraus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Kraus. Carl Kraus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kraus, Carl, et al.. (2025). Integrated phase I pharmacokinetics and pharmacodynamics of epinephrine administered through sublingual film, autoinjector, or manual injection. Annals of Allergy Asthma & Immunology. 134(5). 580–586.

Benedetti, Francesca, Emmanuel F. Mongodin, Jonathan H. Badger, et al.. (2024). Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU. Journal of Translational Medicine. 22(1). 269–269. 1 indexed citations

Golden, David M., Jay R. Lieberman, David I. Bernstein, et al.. (2024). Pharmacokinetics and Pharmacodynamics of Epinephrine Following Administration via Sublingual Film, Autoinjector, or Manual Injection. Journal of Allergy and Clinical Immunology. 153(2). AB12–AB12. 1 indexed citations

Kraus, Carl, et al.. (2022). Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity. Frontiers in Chemistry. 10. 798006–798006. 5 indexed citations

Krizsan, Andor, et al.. (2022). Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity. International Journal of Molecular Sciences. 23(6). 3150–3150. 7 indexed citations

Volke, Daniela, et al.. (2019). Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs. Frontiers in Chemistry. 7. 753–753. 6 indexed citations

Ostorházi, Eszter, et al.. (2018). Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development. Frontiers in Chemistry. 6. 359–359. 17 indexed citations

Ötvös, László, et al.. (2018). Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo. Frontiers in Chemistry. 6. 309–309. 40 indexed citations

Kraus, Carl, et al.. (2015). Clinical Implications of Patient-Provider Agreements in Opioid Prescribing. Current Drug Safety. 10(2). 159–164. 10 indexed citations

10.

Kraus, Carl, et al.. (2015). Ambush of Clostridium difficile Spores by Ramoplanin: Activity in an In Vitro Model. Antimicrobial Agents and Chemotherapy. 59(5). 2525–2530. 23 indexed citations

11.

Hansberry, David R., et al.. (2014). Health Literacy in Vascular and Interventional Radiology: A Comparative Analysis of Online Patient Education Resources. CardioVascular and Interventional Radiology. 37(4). 1034–1040. 29 indexed citations

12.

McAllister, Ryan, Timothy R. Franson, & Carl Kraus. (2013). The Practicing Clinician and Regulatory Safety Concerns. Current Drug Safety. 8(1). 17–24. 2 indexed citations

13.

Kraus, Carl, et al.. (2013). Improving the Effect of FDA-Mandated Drug Safety Alerts with Internet- Based Continuing Medical Education. Current Drug Safety. 8(1). 11–16. 10 indexed citations

14.

Oliver, Juan, Omar H. Maarouf, Faisal H. Cheema, et al.. (2012). SDF-1 activates papillary label-retaining cells during kidney repair from injury. American Journal of Physiology-Renal Physiology. 302(11). F1362–F1373. 20 indexed citations

15.

Kraus, Carl, et al.. (2011). The Safety Record of Fusidic Acid in Non-US Markets: A Focus on Skin Infections. Clinical Infectious Diseases. 52(suppl_7). S527–S537. 24 indexed citations

16.

Kraus, Carl. (2008). Low hanging fruit in infectious disease drug development. Current Opinion in Microbiology. 11(5). 434–438. 29 indexed citations

17.

Kraus, Carl, et al.. (2007). CRAFT: Facilitating clinical trial execution quality.. PubMed. 1016–1016. 1 indexed citations

18.

Kraus, Carl, et al.. (2004). Inhibition of Mycobacterium tuberculosis AhpD, an Element of the Peroxiredoxin Defense against Oxidative Stress. Antimicrobial Agents and Chemotherapy. 48(7). 2424–2430. 15 indexed citations

19.

Kirman, Joanna R., Amy Li, Carl Kraus, et al.. (2002). Enhanced Immunogenicity to Mycobacterium tuberculosis by Vaccination with an Alphavirus Plasmid Replicon Expressing Antigen 85A. Infection and Immunity. 71(1). 575–579. 58 indexed citations

20.

Srinivasan, Arjun, Carl Kraus, David DeShazer, et al.. (2001). Glanders in a Military Research Microbiologist. New England Journal of Medicine. 345(4). 256–258. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact